In this issue of Cardiac Electrophysiology Clinics, guest editors Drs. Ali R. Keramati and Mohammadali Habibi bring their considerable expertise to the topic of Advances in Antiarrhythmic Drug Therapy. Advances in antiarrhythmic drug therapy have led to significant progress in the management of cardiac arrhythmias, offering clinicians a range of medications to effectively treat and control irregular heart rhythms. The development of new drug classes and improved understanding of their mechanisms of action have enhanced patient outcomes and provided more personalized treatment options. In this issues, top experts explore key topics in this area of cardiac electrophysiology.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. viii 7. Foreword - p. ix 8. Preface - p. xi 9. Ionic and Cellular Basis of Antiarrhythmic Drug Therapy and Its Proarrhythmic Risks - p. 1 10. Pharmacokinetics and Pharmacodynamics of Antiarrhythmic Drugs - p. 15 11. Arrhythmogenic and Side Effects of Antiarrhythmic Medications - p. 29 12. Advances in Antiarrhythmic Drug Therapy: Pharmacologic Management of Supraventricular Tachycardia - p. 45 13. Antiarrhythmic Drug Therapy for Acute Management of Atrial Fibrillation and Atrial Flutter - p. 57 14. Advances in Antiarrhythmic Drug Therapy: Chronic Maintenance of Normal Sinus Rhythm Using Anti-arrhythmic Drugs in Patients with Atrial Fibrillation and Atrial Flutter - p. 67 15. Antiarrhythmic Medications for Acute Management of Ventricular Arrhythmias - p. 79 16. Antiarrhythmic Medications in Patients with Adult Congenital Heart Disease - p. 91 17. Advances in Antiarrhythmic Drug Therapy: Potentials and Challenges - p. 109
In this issue of Cardiac Electrophysiology Clinics, guest editors Drs. Ali R. Keramati and Mohammadali Habibi bring their considerable expertise to the topic of Advances in Antiarrhythmic Drug Therapy. Advances in antiarrhythmic drug therapy have led to significant progress in the management of cardiac arrhythmias, offering clinicians a range of medications to effectively treat and control irregular heart rhythms. The development of new drug classes and improved understanding of their mechanisms of action have enhanced patient outcomes and provided more personalized treatment options. In this issues, top experts explore key topics in this area of cardiac electrophysiology.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. viii 7. Foreword - p. ix 8. Preface - p. xi 9. Ionic and Cellular Basis of Antiarrhythmic Drug Therapy and Its Proarrhythmic Risks - p. 1 10. Pharmacokinetics and Pharmacodynamics of Antiarrhythmic Drugs - p. 15 11. Arrhythmogenic and Side Effects of Antiarrhythmic Medications - p. 29 12. Advances in Antiarrhythmic Drug Therapy: Pharmacologic Management of Supraventricular Tachycardia - p. 45 13. Antiarrhythmic Drug Therapy for Acute Management of Atrial Fibrillation and Atrial Flutter - p. 57 14. Advances in Antiarrhythmic Drug Therapy: Chronic Maintenance of Normal Sinus Rhythm Using Anti-arrhythmic Drugs in Patients with Atrial Fibrillation and Atrial Flutter - p. 67 15. Antiarrhythmic Medications for Acute Management of Ventricular Arrhythmias - p. 79 16. Antiarrhythmic Medications in Patients with Adult Congenital Heart Disease - p. 91 17. Advances in Antiarrhythmic Drug Therapy: Potentials and Challenges - p. 109
